跳至主要内容
临床试验/JPRN-UMIN000015423
JPRN-UMIN000015423已完成未知

The prevention of Alzheimer's disease through regulation of amyloid beta synthesis and brake-down by propolis intake - The prevention of Alzheimer's disease by propolis intake

Kyoto Prefectural University of Medicine, Graduate School of Medical Science0 个研究点目标入组 60 人开始时间: 2014年10月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who did not agree with this study 2) Patients with severe renal dysfunction and severe hepatic dysfunction 3) Type 1 diabetes and other specific types of diabetes resulting from specific genetic syndromes, surgery, drugs, malnutrition, infections, and other illnesses 4) Patients treated with insulin 5) Patients with dementia or neurodegenerating disease 6) Patients who is taking drugs which affect the cognitive function 7) Patients who changed oral hypoglycemic drugs significantly 8) Patients who changed drugs which affect pH of interstitial fluid 9) Patients judged by the investigator to be ineligible for some other reason

研究者

发起方
Kyoto Prefectural University of Medicine, Graduate School of Medical Science

相似试验